Emmaus Life Sciences (EMMA) Assets (2010 - 2026)
Emmaus Life Sciences' Assets was $16.37 million in Q2 2026, down 29.9% from $23.34 million a year earlier and down 12.4% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Assets at Emmaus Life Sciences came in at $21.44 million, down 9.2% from FY2024.
- Assets has now declined for five consecutive years, with a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- In earlier years, Assets was $23.6 million in FY2024 (-32.9%), $35.18 million in FY2023 (-27.1%), $48.23 million in FY2022 (-15.0%) and $56.73 million in FY2021 (-4.7%).
- The Q2 2026 figure marks the lowest quarterly Assets since Q3 2018.
- Compared with a year earlier, Assets has declined for 11 straight quarters, with an average decline of 23.6% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2023 (growth of 12.4%); the worst was Q2 2024 (a decline of 48.4%).
- Per Business Quant data, EMMA's Assets in the three quarters before Q2 2026 was $18.7 million (Q1 2026), $21.44 million (Q4 2025) and $20.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.64 Bn | 1,118.23 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 626.55 Bn | 545.08 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 498.79 Bn | 471.91 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 371.66 Bn | 326.04 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 299.96 Bn | 263.95 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 263.22 Bn | 236.91 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.03 Bn | 192.43 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.20 Bn | 165.40 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | 16.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.37 Mn |
| Mar 31, 2026 | 18.70 Mn |
| Dec 31, 2025 | 21.44 Mn |
| Sep 30, 2025 | 20.76 Mn |
| Jun 30, 2025 | 23.34 Mn |
| Mar 31, 2025 | 22.48 Mn |
| Dec 31, 2024 | 23.60 Mn |
| Sep 30, 2024 | 27.34 Mn |
| Jun 30, 2024 | 25.94 Mn |
| Mar 31, 2024 | 29.54 Mn |
| Dec 31, 2023 | 35.18 Mn |
| Sep 30, 2023 | 47.45 Mn |
| Jun 30, 2023 | 50.29 Mn |
| Mar 31, 2023 | 48.95 Mn |
| Dec 31, 2022 | 48.23 Mn |
| Sep 30, 2022 | 42.20 Mn |
| Jun 30, 2022 | 45.99 Mn |
| Mar 31, 2022 | 51.49 Mn |
| Dec 31, 2021 | 56.73 Mn |
| Sep 30, 2021 | 60.06 Mn |
API Access
Emmaus Life Sciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();